These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4445956)

  • 41. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Report on pregnancy complicated by wild rubella--spring, 1971.
    Med J Aust; 1973 Sep; 2(11):545-7. PubMed ID: 4748583
    [No Abstract]   [Full Text] [Related]  

  • 43. Therapeutic abortion employing the synergistic action of extra-amniotic prostaglandin E 2 and an intravenous infusion of oxytocin.
    Morewood GA
    J Obstet Gynaecol Br Commonw; 1973 May; 80(5):473-5. PubMed ID: 4712943
    [No Abstract]   [Full Text] [Related]  

  • 44. Letter: Adverse reactions to intra-amniotic urea and prostaglandin.
    Craft I; Bowen-Simpkins P
    Br Med J; 1974 May; 2(5916):446. PubMed ID: 4835318
    [No Abstract]   [Full Text] [Related]  

  • 45. An analysis of the first 200 legal abortions at the Johannesburg General Hospital.
    Kopenhager T; Kort H; Bloch B
    S Afr Med J; 1978 May; 53(21):858-60. PubMed ID: 694641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Letter: Adverse reactions to intra-amniotic urea and prostaglandin.
    Ross AH; Whitehouse WL
    Br Med J; 1974 Mar; 1(5908):642. PubMed ID: 4821034
    [No Abstract]   [Full Text] [Related]  

  • 47. Intrauterine extra-amniotic administration of prostaglandin F 2 for therapeutic abortion. Early myometrial effects.
    Braaksma JT; Brenner WE; Fishburne JI; Staurovsky L
    Am J Obstet Gynecol; 1972 Oct; 114(4):511-5. PubMed ID: 4653834
    [No Abstract]   [Full Text] [Related]  

  • 48. Letter: Adverse reactions to intra-amniotic prostaglandin.
    Karim SM
    Br Med J; 1974 Aug; 3(5926):347. PubMed ID: 4414105
    [No Abstract]   [Full Text] [Related]  

  • 49. Letter: Adverse reactions to intra-amniotic prostaglandin.
    Br Med J; 1974 May; 2(5915):382-3. PubMed ID: 4835847
    [No Abstract]   [Full Text] [Related]  

  • 50. Chronoperiodicity in the response to the intra-amniotic injection of prostaglandin F 2 in the human.
    Smith ID; Shearman RP; Korda AR
    Nature; 1973 Jan; 241(5387):279-80. PubMed ID: 4701887
    [No Abstract]   [Full Text] [Related]  

  • 51. Continuous extra-amniotic prostaglandin E 2 for therapeutic termination and the effectiveness of various infusion rates and dosages.
    Midwinter A; Shepherd A; Bowen M
    J Obstet Gynaecol Br Commonw; 1973 Apr; 80(4):371-3. PubMed ID: 4704686
    [No Abstract]   [Full Text] [Related]  

  • 52. Induction of therapeutic abortion by intra-amniotic injection of urea.
    Greenhalfjo ; Diggory PL
    Br Med J; 1971 Jan; 1(5739):28-9. PubMed ID: 5539139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Injuries of the cervix after induced midtrimester abortion.
    Bradley-Watson PJ; Beard RJ; Craft IL
    J Obstet Gynaecol Br Commonw; 1973 Mar; 80(3):284-5. PubMed ID: 4703270
    [No Abstract]   [Full Text] [Related]  

  • 54. Ultrastructural alterations of the amniocytes in 2 patients with rubella during the first trimester of pregnancy.
    Straussberg R; Amir J; Harel L; Djaldetti M
    Fetal Diagn Ther; 1995; 10(1):60-5. PubMed ID: 7710681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intrauterine administration of 15 (S)-15-methyl-prostaglandin F 2 for induction of abortion.
    Bygdeman M; Béguin F; Toppozada M; Wiqvist N; Bergström S
    Lancet; 1972 Jun; 1(7764):1336-7. PubMed ID: 4113424
    [No Abstract]   [Full Text] [Related]  

  • 56. Therapeutic abortion by local administration of prostaglandin.
    Wiqvist N; Bygdeman M
    Lancet; 1970 Oct; 2(7675):716-7. PubMed ID: 4195946
    [No Abstract]   [Full Text] [Related]  

  • 57. A generalized epileptiform convulsion after intra-amniotic prostaglandin E2.
    Brash JH
    Br J Obstet Gynaecol; 1976 Aug; 83(8):665-6. PubMed ID: 952799
    [No Abstract]   [Full Text] [Related]  

  • 58. Osseous manifestations of gestational rubella in young human fetuses.
    Sekeles E; Ornoy A
    Am J Obstet Gynecol; 1975 Jun; 122(3):307-12. PubMed ID: 1130455
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter: Extra-amniotic administration of prostaglandins.
    MacKenzie IZ; Hillier K
    Lancet; 1974 Mar; 1(7856):511. PubMed ID: 4131916
    [No Abstract]   [Full Text] [Related]  

  • 60. [Recurrent viral diseases in pregnancy, rubella and the right to therapeutic abortion. 1953].
    Peralta Ramos A
    Ginecol Obstet Mex; 2008 Jul; 76(7):421-7. PubMed ID: 18798444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.